HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk

BACKGROUND & AIMS: Therapeutic, clinical trial entry and stratification decisions for hepatocellular carcinoma (HCC) are made based on prognostic assessments, using clinical staging systems based on small numbers of empirically selected variables that insufficiently account for differences in bi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatology
Autori principali: Morris, Jeffrey S., Hassan, Manal M., Zohner, Ye Emma, Wang, Zeya, Xiao, Lianchun, Rashid, Asif, Haque, Abedul, Abdel-Wahab, Reham, Mohamed, Yehia A., Ballard, Karri L., Wolff, Robert A., George, Bhawana, Li, Liang, Allen, Genevera, Weylandt, Michael, Li, Donghui, Wang, Wenyi, Raghav, Kanwal, Yao, James, Amin, Hesham M., Kaseb, Ahmed Omar
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956911/
https://ncbi.nlm.nih.gov/pubmed/32931023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31555
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi